MedPath

EMORY UNIVERSITY

EMORY UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1836-12-10
Employees
10K
Market Cap
-
Website
http://www.emory.edu

Study Effects of Intermittent Hypoxia on Restoring Hand Function Following SCI

Phase 1
Completed
Conditions
Spinal Cord Injury
Interventions
Drug: Acute Intermittent Hypoxia (AIH)
Other: SHAM-Intermittent Room Air
First Posted Date
2011-01-07
Last Posted Date
2016-01-26
Lead Sponsor
Emory University
Target Recruit Count
53
Registration Number
NCT01272336
Locations
🇺🇸

Emory Center for Rehabilitation Medicine, Atlanta, Georgia, United States

Intermittent Hypoxia Elicits Prolonged Restoration of Motor Function in Human SCI

Phase 1
Completed
Conditions
Spinal Cord Injury
Interventions
Other: Acute intermittent hypoxia
Other: Room air
First Posted Date
2011-01-07
Last Posted Date
2013-11-21
Lead Sponsor
Emory University
Target Recruit Count
19
Registration Number
NCT01272349
Locations
🇺🇸

Shepherd Center, Atlanta, Georgia, United States

🇺🇸

Rehabilitation Institute of Chicago, Chicago, Illinois, United States

A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer

Phase 2
Terminated
Conditions
Breast Neoplasms
Breast Cancer
Cancer of the Breast
Interventions
First Posted Date
2011-01-07
Last Posted Date
2014-09-22
Lead Sponsor
Emory University
Target Recruit Count
5
Registration Number
NCT01272141
Locations
🇺🇸

Grady Memorial Hospital, Atlanta, Georgia, United States

🇺🇸

Emory University Winship Cancer Institute, Atlanta, Georgia, United States

🇺🇸

Emory Midtown (Crawford Long Hospital), Atlanta, Georgia, United States

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer

Not Applicable
Completed
Conditions
Breast Tumors
Cancer of Breast
Neoplasms, Breast
Breast Cancer
Cancer of the Breast
Human Mammary Carcinoma
Breast Neoplasms
Interventions
Procedure: Remove tumor only
Procedure: Removal of tumor and tissue
First Posted Date
2011-01-07
Last Posted Date
2015-08-17
Lead Sponsor
Emory University
Target Recruit Count
79
Registration Number
NCT01271738
Locations
🇺🇸

Emory University Winship Cancer Institute, Atlanta, Georgia, United States

Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer

Phase 2
Completed
Conditions
Thyroid Cancer
Interventions
First Posted Date
2011-01-05
Last Posted Date
2021-02-17
Lead Sponsor
Emory University
Target Recruit Count
42
Registration Number
NCT01270321
Locations
🇺🇸

Emory University Winship Cancer Institute, Atlanta, Georgia, United States

🇺🇸

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

🇺🇸

Emory University Hospital Midtown, Atlanta, Georgia, United States

Characterization of Human Memory Immune Responses to Prior Yellow Fever Vaccination

Conditions
Yellow Fever Vaccine
First Posted Date
2010-11-19
Last Posted Date
2024-11-04
Lead Sponsor
Emory University
Target Recruit Count
300
Registration Number
NCT01244802
Locations
🇺🇸

The Hope clinic of Emory Vaccine Center, Decatur, Georgia, United States

Satisfaction of Treatment Among Elderly Patients With Insulin Therapy

Phase 4
Completed
Conditions
Diabetes Mellitus
Interventions
Drug: Glargine
Device: glargine via insulin pen
First Posted Date
2010-11-15
Last Posted Date
2018-10-31
Lead Sponsor
Emory University
Target Recruit Count
49
Registration Number
NCT01240200
Locations
🇺🇸

Grady Memorial Hospital, Atlanta, Georgia, United States

Botulinum Toxin in the Treatment of Raynaud's

Not Applicable
Completed
Conditions
Raynaud's Syndrome
Interventions
First Posted Date
2010-11-04
Last Posted Date
2014-04-21
Lead Sponsor
Emory University
Target Recruit Count
10
Registration Number
NCT01233999
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Systems Biology of Trivalent Influenza Vaccine (TIV) in Young and Elderly

Not Applicable
Completed
Conditions
Influenza
Interventions
Biological: trivalent Influenza vaccine (TIV)
First Posted Date
2010-11-02
Last Posted Date
2015-11-30
Lead Sponsor
Emory University
Target Recruit Count
66
Registration Number
NCT01232868
Locations
🇺🇸

Hope Clinic of the Emory Vaccine Center, Decatur, Georgia, United States

Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia

Not Applicable
Terminated
Conditions
Leukemia
ALL
Acute Lymphoblastic Leukemia
Interventions
First Posted Date
2010-10-29
Last Posted Date
2014-12-01
Lead Sponsor
Emory University
Target Recruit Count
1
Registration Number
NCT01230788
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

Children's Healthcare of Atlanta, Atlanta, Georgia, United States

🇺🇸

The children's Mercy Hospital, Kansas City, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath